Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.

Stella Talic, Shivangi Shah, Holly Wild, Danijela Gasevic, Ashika Maharaj, Zanfina Ademi, Xue Li, Wei Xu, Ines Mesa-Eguiagaray, Jasmin Rostron, Evropi Theodoratou, Xiaomeng Zhang, Ashmika Motee, Danny Liew, Dragan Ilic
Author Information
  1. Stella Talic: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia stella.talic@monash.edu. ORCID
  2. Shivangi Shah: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  3. Holly Wild: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  4. Danijela Gasevic: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  5. Ashika Maharaj: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  6. Zanfina Ademi: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  7. Xue Li: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  8. Wei Xu: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  9. Ines Mesa-Eguiagaray: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  10. Jasmin Rostron: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  11. Evropi Theodoratou: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  12. Xiaomeng Zhang: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  13. Ashmika Motee: Centre for Global Health, The Usher Institute, University of Edinburgh, Edinburgh, UK.
  14. Danny Liew: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.
  15. Dragan Ilic: School of Public Health and Preventive Medicine, Monash University, Melbourne, 3004 VIC, Australia.

Abstract

OBJECTIVE: To review the evidence on the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
DESIGN: Systematic review and meta-analysis.
DATA SOURCES: Medline, Embase, CINAHL, Biosis, Joanna Briggs, Global Health, and World Health Organization COVID-19 database (preprints).
ELIGIBILITY CRITERIA FOR STUDY SELECTION: Observational and interventional studies that assessed the effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.
MAIN OUTCOME MEASURES: The main outcome measure was incidence of covid-19. Secondary outcomes included SARS-CoV-2 transmission and covid-19 mortality.
DATA SYNTHESIS: DerSimonian Laird random effects meta-analysis was performed to investigate the effect of mask wearing, handwashing, and physical distancing measures on incidence of covid-19. Pooled effect estimates with corresponding 95% confidence intervals were computed, and heterogeneity among studies was assessed using Cochran's Q test and the I metrics, with two tailed P values.
RESULTS: 72 studies met the inclusion criteria, of which 35 evaluated individual public health measures and 37 assessed multiple public health measures as a "package of interventions." Eight of 35 studies were included in the meta-analysis, which indicated a reduction in incidence of covid-19 associated with handwashing (relative risk 0.47, 95% confidence interval 0.19 to 1.12, I=12%), mask wearing (0.47, 0.29 to 0.75, I=84%), and physical distancing (0.75, 0.59 to 0.95, I=87%). Owing to heterogeneity of the studies, meta-analysis was not possible for the outcomes of quarantine and isolation, universal lockdowns, and closures of borders, schools, and workplaces. The effects of these interventions were synthesised descriptively.
CONCLUSIONS: This systematic review and meta-analysis suggests that several personal protective and social measures, including handwashing, mask wearing, and physical distancing are associated with reductions in the incidence covid-19. Public health efforts to implement public health measures should consider community health and sociocultural needs, and future research is needed to better understand the effectiveness of public health measures in the context of covid-19 vaccination.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178692.

References

  1. J Travel Med. 2020 May 18;27(3): [PMID: 32181488]
  2. Ann Transl Med. 2020 Jun;8(11):689 [PMID: 32617309]
  3. Emerg Infect Dis. 2020 Nov;26(11):2607-2616 [PMID: 32931726]
  4. Sci Total Environ. 2020 Nov 10;742:140430 [PMID: 32623158]
  5. J Infect. 2020 Jul;81(1):107-114 [PMID: 32335167]
  6. J Family Med Prim Care. 2021 Feb;10(2):1003-1008 [PMID: 34041112]
  7. Science. 2022 Jan 14;375(6577):eabi9069 [PMID: 34855513]
  8. J Med Internet Res. 2020 Nov 13;22(11):e21372 [PMID: 33108317]
  9. BMC Public Health. 2021 Apr 29;21(1):827 [PMID: 33926406]
  10. Public Health. 2020 Dec;189:54-59 [PMID: 33160088]
  11. BMC Infect Dis. 2021 Sep 8;21(1):928 [PMID: 34496771]
  12. Health Policy Plan. 2021 Jun 3;36(5):620-629 [PMID: 33899097]
  13. BMC Med. 2020 Oct 5;18(1):316 [PMID: 33012285]
  14. JAMA. 2020 Sep 1;324(9):859-870 [PMID: 32745200]
  15. S Afr Med J. 2020 Oct 28;110(11):1119-1123 [PMID: 33403990]
  16. Clin Infect Dis. 2020 Jul 28;71(15):866-869 [PMID: 32246149]
  17. Am J Trop Med Hyg. 2020 Dec;103(6):2400-2411 [PMID: 33124541]
  18. J Transp Geogr. 2020 Dec;89:102894 [PMID: 33519126]
  19. Lancet Digit Health. 2021 Mar;3(3):e148-e157 [PMID: 33483277]
  20. Colomb Med (Cali). 2020 Jun 30;51(2):e4266 [PMID: 33012884]
  21. BMC Med Res Methodol. 2015 Nov 14;15:99 [PMID: 26573817]
  22. Lancet Child Adolesc Health. 2020 May;4(5):397-404 [PMID: 32272089]
  23. Emerg Infect Dis. 2021 Jan;27(1): [PMID: 33080168]
  24. Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574 [PMID: 32267544]
  25. BMJ Glob Health. 2020 May;5(5): [PMID: 32467353]
  26. Lancet Glob Health. 2020 Apr;8(4):e488-e496 [PMID: 32119825]
  27. Ann Epidemiol. 2021 May;57:46-53 [PMID: 33596446]
  28. BMC Med. 2020 May 7;18(1):124 [PMID: 32375776]
  29. Int J Infect Dis. 2020 Oct;99:57-61 [PMID: 32745628]
  30. Int J Infect Dis. 2020 Oct;99:466-472 [PMID: 32829052]
  31. Sci Total Environ. 2020 Jul 20;727:138394 [PMID: 32334207]
  32. Psychiatry Res. 2020 Nov;293:113429 [PMID: 32882598]
  33. Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1174-1183 [PMID: 33690835]
  34. Indian J Public Health. 2020 Jun;64(Supplement):S156-S167 [PMID: 32496248]
  35. JAMA. 2020 Apr 21;323(15):1441-1442 [PMID: 32167525]
  36. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9): [PMID: 33574041]
  37. CMAJ. 2020 May 25;192(21):E566-E573 [PMID: 32385067]
  38. Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S120-S126 [PMID: 33009800]
  39. Euro Surveill. 2020 May;25(21): [PMID: 32489179]
  40. Anesth Analg. 2020 Jul;131(1):86-92 [PMID: 32243287]
  41. Indian J Public Health. 2020 Jun;64(Supplement):S142-S146 [PMID: 32496246]
  42. N Engl J Med. 2020 Jul 23;383(4):303-305 [PMID: 32412711]
  43. J Prev Med Public Health. 2020 Jul;53(4):228-232 [PMID: 32752591]
  44. Am J Infect Control. 2021 Aug;49(8):1036-1042 [PMID: 33577824]
  45. Lancet. 2020 Nov 21;396(10263):1614-1616 [PMID: 33159850]
  46. Lancet Public Health. 2020 May;5(5):e271-e278 [PMID: 32251626]
  47. Emerg Med Australas. 2020 Oct;32(5):867-869 [PMID: 32578926]
  48. Sci Total Environ. 2021 Oct 1;789:147876 [PMID: 34051508]
  49. Clin Infect Dis. 2021 Oct 5;73(7):e1863-e1869 [PMID: 32634828]
  50. Nat Med. 2020 May;26(5):640-642 [PMID: 32273610]
  51. Cad Saude Publica. 2020 Oct 19;36(10):e00213920 [PMID: 33084836]
  52. Clin Infect Dis. 2021 Oct 5;73(7):e1822-e1829 [PMID: 32877921]
  53. J Glob Health. 2020 Dec;10(2):020513 [PMID: 33312506]
  54. Cien Saude Colet. 2020 Sep;25(9):3365-3376 [PMID: 32876275]
  55. Int J Environ Res Public Health. 2021 Apr 17;18(8): [PMID: 33920613]
  56. BMC Public Health. 2007 Aug 15;7:208 [PMID: 17697389]
  57. PLoS One. 2020 Jul 30;15(7):e0236619 [PMID: 32730356]
  58. Am J Med Sci. 2021 May;361(5):575-584 [PMID: 33775425]
  59. BMC Public Health. 2021 May 21;21(1):965 [PMID: 34020613]
  60. J Infect. 2020 Sep;81(3):e70-e71 [PMID: 32579981]
  61. BMJ. 2016 Oct 12;355:i4919 [PMID: 27733354]
  62. J Public Econ. 2021 Jan;193:104346 [PMID: 33281237]
  63. Crit Care. 2021 Jul 12;25(1):244 [PMID: 34253247]
  64. Travel Med Infect Dis. 2020 Nov - Dec;38:101901 [PMID: 33049360]
  65. Lancet. 2020 Nov 7;396(10261):1525-1534 [PMID: 32979936]
  66. Ann Intern Med. 2021 Mar;174(3):335-343 [PMID: 33205991]
  67. Risk Manag Healthc Policy. 2020 Sep 23;13:1695-1700 [PMID: 33061703]
  68. Proc Natl Acad Sci U S A. 2021 Jan 26;118(4): [PMID: 33431650]
  69. Science. 2021 May 20;: [PMID: 34016743]
  70. Lancet Child Adolesc Health. 2020 Nov;4(11):807-816 [PMID: 32758454]
  71. PLoS Negl Trop Dis. 2021 Jan 22;15(1):e0009070 [PMID: 33481804]
  72. Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142 [PMID: 31643080]
  73. SAGE Open Med. 2021 Jun 06;9:20503121211022973 [PMID: 34164126]
  74. Int J Infect Dis. 2021 Jan;102:247-253 [PMID: 33129965]
  75. MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1170-1172 [PMID: 32853185]
  76. Public Health Rep. 2021 Jul-Aug;136(4):475-482 [PMID: 33909541]
  77. Z Gesundh Wiss. 2022;30(3):583-586 [PMID: 32837842]
  78. Am J Infect Control. 2020 Aug;48(8):958-960 [PMID: 32461066]
  79. Eur J Clin Invest. 2021 Apr;51(4):e13484 [PMID: 33400268]
  80. Lancet. 2020 Apr 18;395(10232):1243-1244 [PMID: 32305087]
  81. EClinicalMedicine. 2021 Apr;34:100807 [PMID: 33817612]
  82. Epidemiol Infect. 2020 Jun 10;148:e115 [PMID: 32517845]
  83. BMJ Open. 2020 Dec 10;10(12):e041778 [PMID: 33303462]
  84. Int J Epidemiol. 2020 Oct 1;49(5):1454-1467 [PMID: 32814959]
  85. BMC Med. 2020 May 29;18(1):160 [PMID: 32466757]
  86. Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788 [PMID: 32526627]
  87. BMJ. 2019 Aug 28;366:l4898 [PMID: 31462531]
  88. One Health. 2021 Jan 05;12:100213 [PMID: 33506086]
  89. Br Med Bull. 2020 Dec 15;136(1):46-87 [PMID: 33030513]
  90. Euro Surveill. 2020 Dec;25(49): [PMID: 33303066]
  91. Minerva Pediatr. 2020 Jun;72(3):226-235 [PMID: 32613821]
  92. Proc Natl Acad Sci U S A. 2021 Mar 23;118(12): [PMID: 33658331]
  93. JAMA Netw Open. 2021 Jun 1;4(6):e2115985 [PMID: 34097044]
  94. Travel Med Infect Dis. 2020 Sep - Oct;37:101660 [PMID: 32247931]
  95. Epidemiol Health. 2020;42:e2020035 [PMID: 32512664]
  96. Emerg Infect Dis. 2020 Oct;26(10):2406-2410 [PMID: 32487283]
  97. Sci Total Environ. 2020 Jul 10;725:138539 [PMID: 32304973]
  98. JAMA Netw Open. 2020 Jul 1;3(7):e2016099 [PMID: 32701162]
  99. PLoS One. 2021 Jan 29;16(1):e0245656 [PMID: 33513157]
  100. PLoS Med. 2020 Oct 6;17(10):e1003376 [PMID: 33022016]
  101. Appl Health Econ Health Policy. 2020 Aug;18(4):509-517 [PMID: 32495067]
  102. JAMA Netw Open. 2021 Jan 4;4(1):e2032101 [PMID: 33471117]
  103. J Infect. 2021 Sep;83(3):281-293 [PMID: 34161818]
  104. PLoS Comput Biol. 2011 Feb 10;7(2):e1001076 [PMID: 21347316]
  105. Int J Infect Dis. 2020 Nov;100:42-49 [PMID: 32800859]
  106. Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717 [PMID: 33502002]
  107. Nat Hum Behav. 2020 Dec;4(12):1303-1312 [PMID: 33199859]
  108. Travel Med Infect Dis. 2020 May - Jun;35:101654 [PMID: 32268195]
  109. J Med Internet Res. 2021 Jan 22;23(1):e24591 [PMID: 33351774]
  110. Health Aff (Millwood). 2020 Jul;39(7):1237-1246 [PMID: 32407171]
  111. Clin Infect Dis. 2021 Nov 16;73(10):1871-1878 [PMID: 33704422]
  112. Ther Adv Infect Dis. 2021 Jun 18;8:20499361211024372 [PMID: 34211709]
  113. Emerg Microbes Infect. 2020 Dec;9(1):988-990 [PMID: 32321369]
  114. Geroscience. 2020 Aug;42(4):1075-1082 [PMID: 32529592]
  115. BMC Public Health. 2021 May 29;21(1):1015 [PMID: 34051769]
  116. Med J Aust. 2021 Aug 16;215(4):149-151.e1 [PMID: 34296443]
  117. JAMA. 2020 May 19;323(19):1915-1923 [PMID: 32275295]
  118. J Urban Health. 2020 Jun;97(3):348-357 [PMID: 32333243]
  119. J Clin Epidemiol. 2009 Oct;62(10):1006-12 [PMID: 19631508]
  120. Health Aff (Millwood). 2020 Aug;39(8):1419-1425 [PMID: 32543923]
  121. Virol J. 2021 Aug 13;18(1):166 [PMID: 34389034]
  122. Diabetes Metab Syndr. 2020 Jul - Aug;14(4):707-711 [PMID: 32426062]
  123. CMAJ. 2016 May 17;188(8):567-574 [PMID: 26952529]

MeSH Term

COVID-19
COVID-19 Vaccines
Communicable Disease Control
Global Health
Hand Disinfection
Humans
Incidence
Masks
Physical Distancing
Public Health
Quarantine
SARS-CoV-2
Schools
Travel
World Health Organization

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0covid-19healthmeasures0publicincidencemeta-analysisstudiesreviewSARS-CoV-2transmissioneffectivenessreducingmortalityassessedmaskwearinghandwashingphysicaldistancingDATAHealthoutcomesincludedeffectseffect95%confidenceheterogeneity35interventionsassociated4775systematicOBJECTIVE:evidenceDESIGN:SystematicSOURCES:MedlineEmbaseCINAHLBiosisJoannaBriggsGlobalWorldOrganizationCOVID-19databasepreprintsELIGIBILITYCRITERIAFORSTUDYSELECTION:ObservationalinterventionalMAINOUTCOMEMEASURES:mainoutcomemeasureSecondarySYNTHESIS:DerSimonianLairdrandomperformedinvestigatePooledestimatescorrespondingintervalscomputedamongusingCochran'sQtestmetricstwotailedPvaluesRESULTS:72metinclusioncriteriaevaluatedindividual37multiple"package"Eightindicatedreductionrelativeriskinterval19112I=12%29I=84%5995I=87%OwingpossiblequarantineisolationuniversallockdownsclosuresbordersschoolsworkplacessynthesiseddescriptivelyCONCLUSIONS:suggestsseveralpersonalprotectivesocialincludingreductionsPubliceffortsimplementconsidercommunitysocioculturalneedsfutureresearchneededbetterunderstandcontextvaccinationSYSTEMATICREVIEWREGISTRATION:PROSPEROCRD42020178692Effectivenessmortality:

Similar Articles

Cited By